Angiotensin-converting enzyme genotype is associated with Alzheimer disease in the Japanese population

Neuroscience Letters

Volumn 277, Issue 1, 1999, Pages 65-67

  Hu, Jianguo ^a   Miyatake, Fumiko ^a   Aizu, Yoshinori ^a   Nakagawa, Hachirou ^a   Nakamura, Sigenobu ^b   Tamaoka, Akira ^c   Takahash, Ryosuke ^d   Urakami, Katsuya ^e   Shoji, Mikio ^f  

^a BML   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d Tokyo Metropol Inst N   (Japan)

^e TOTTORI UNIVERSITY   (Japan)

^f GUNMA UNIVERSITY   (Japan)

Author keywords

Alzheimer disease; Angiotensin converting enzyme; Genotype; Risk factor

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENOTYPE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

AGED; ALZHEIMER DISEASE; BRAIN CHEMISTRY; GENE FREQUENCY; GENOTYPE; HUMANS; JAPAN; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0032706653     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00827-7     Document Type: Article

References (20)

1. Abbud Z.A., Wilson A.C., Cosgrove N.M., Kosis J.B. Angiotensin-converting enzyme gene polymorphism in systemic hypertension. Am. J. Cardiol. 81:1998;244-246.
2. Albrecht D., Broser M., Kruger H. Excitory action of angiotensins II and IV on hippocampal neuronal activity in urethane anesthitized rats. Regul. Pept. 70:1997;105-109.
3. Hixson J.E., Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid. Res. 31:1990;545-548.
4. Kakinuma Y., Hama H., Sugiyama F., Goto K., Murakami K., Fukamizu A. Anti-apoptotic action of angiotensin fragments to neuronal cells from angiotensinogen knock-out mice. Neurosci. Lett. 232:1997;167-170.
5. Kakinuma Y., Hama H., Sugiyama F., Yagami K., Goto K., Murakami K., Fukamizu A. Impaired blood-brain barrier function in angiotensinogen-deficient mice. Nat. Med. 4:1998;1078-1080.
6. Kehoe P.G., Russ C., Mcllroy S., Williams H., Holmans P., Holmes C., Liolitsa D., Vahidassr D., Powell J., McGleenon B., Liddell M., Plomin R., Dynan K., Williams N., Neal J., Cairns N.J., Wilcock G., Passmore P., Lovestone S., Williams J., Owen M.J. Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease. Nat. Genet. 21:1999;71-72.
7. Kramar E.A., Harding J.W., Wright J.W. Angiotensin II- and IV-induced changes in cerebral blood flow. Roles of AT1, AT2, and AT4 receptor subtypes. Regul. Pept. 68:1997;131-138.
8. Ledru F., Blanchard D., Battaglis S., Jeunemaitre X., Courbon D., Guize L., Guermonprez J.L., Ducimetiere P., Diebold B. Relation between severity of coronary artery disease, left ventricular function and myocardial infarction, and influence of the ACE I/D gene polymorphism. Am. J. Cardiol. 82:1998;160-165.
9. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 343:1984;939-944.
10. Okuizumi K., Onodera O., Tanaka H., Kobayashi H., Tsuji S., Takahashi H., Oyanagi K., Seki K., Tanaka M., Naruse S., Miyatake T., Mizusawa H., Kanazawa I. ApoE-E4 and early-onset Alzheimer's. Nat. Gene. 7:1994;10-11.
11. Pederson E.S., Harding J.W., Wright J.W. Attenuation of scopolamine-induced spatial learning impairments by an angiotensin IV analog. Regul. Pept. 74:1998;97-103.
12. Pericak-Vance M.A., Haines J.L. Genetic susceptibility to Alzheimer disease. Trends Gent. 11:1995;504-508.
13. Reid I.A. Interactions between AHG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am. J. Physiol. 262:1992;E763-E778.
14. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86:1990;1343-1346.
15. Rigat B., Hubert C., Corvol R., Soubier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucl. Acids Res. 20:1992;1433.
16. Skoog I., Wallin A., Fredman P., Hesse C., Aevarsson O., Karlsson I., Gottfies C.G., Blennow K.A. A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia. Neurology. 50:1998;966-971.
17. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., Roses A.D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:1993;1977-1981.
18. Vleming L.J., van der Pijl J.W., Lemkes H.H., Westendorp R.G, Maassen J.A., Daha M.R., van Es L.A., van Kooten C. The DD genotype of the ACE gene polymorphism is associated with progression of diabetic nephropathy to end stage renal failure in IDDM. Clin. Nephrol. 51:1999;133-140.
19. Wright J.W., Stubley L., Pederson E.S., Kramar E.A., Hanesworth J.M., Harding J.W. Contributions of the brain angiotensin IV-AT4 receptor subtype system to spatial learning. J. Neurosci. 19:1999;3952-3961.
20. Zhuo J., Moeller I., Jenkins T., Chai S.Y., Allen A.M., Ohishi M., Mendelsohn F.A. Mapping tissue angiotensin-converting enzyme and angiotensin AT1 AT2, and AT4 receptors. J. Hypertens. 16:1998;2027-2037.